Sitagliptin-induced hyperthyroidism: a case report

Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, is commonly used to manage type 2 diabetes mellitus (T2DM). Although generally considered safe, recent studies suggest a potential role of DPP-4 inhibitors in modulating immune responses, potentially leading to autoimmune conditions, including...

Full description

Bibliographic Details
Published in:Medičnì Perspektivi
Main Authors: Feras M. Almarshad, Yusuf Jamal, Dushad Ram, Jamal Arif, Kauser Usman
Format: Article
Language:English
Published: Dnipro State Medical University 2025-09-01
Subjects:
sitagliptin
diabetes mellitus
hyperthyroidism
autoimmune thyroid disease
carbimazole
Online Access:https://journals.uran.ua/index.php/2307-0404/article/view/340749

Internet

https://journals.uran.ua/index.php/2307-0404/article/view/340749

Similar Items